E-LIB Suche - Ergebnisse für: Mitselos, Anna

1

Demonstrating Bioequivalence for Two Dose Strengths of Nira..:

Yu, Alex ; Hazra, Anasuya ; Jiao, James Juhui...
Clinical Pharmacokinetics. 63 (2024) 4 - p. 511-527 , 2024

Link: https://doi.org/10.1007/..

2

Ibrutinib does not have clinically relevant interactions wi..:

Jong, Jan ; Mitselos, Anna ; Jurczak, Wojciech...
Pharmacology Research & Perspectives. 8 (2020) 5 - p. , 2020

Link: https://doi.org/10.1002/..

3

Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part ..:

Duran, Ignacio ; Carles, Joan ; Bulat, Iurie...
Clinical Pharmacokinetics. 59 (2020) 9 - p. 1135-1148 , 2020

Link: https://doi.org/10.1007/..

4

An open-label, multicenter, phase Ib study investigating th..:

Belderbos, Bodine P. S. I. ; de Wit, Ronald ; Chien, Caly...
Cancer Chemotherapy and Pharmacology. 82 (2018) 3 - p. 457-468 , 2018

Link: https://doi.org/10.1007/..

5

Discovery and Clinical Evaluation of MK‐8150, A Novel Nitri..:

Knox, Clayton D. ; de Kam, Pieter‐Jan ; Azer, Karim...
Journal of the American Heart Association. 5 (2016) 9 - p. , 2016

Link: https://doi.org/10.1161/..

6

Motilin and ghrelin as prokinetic drug targets:

De Smet, Betty ; Mitselos, Anna ; Depoortere, Inge
Pharmacology & Therapeutics. 123 (2009) 2 - p. 207-223 , 2009

Link: https://doi.org/10.1016/..

7

Desensitization and internalization of the human motilin re..:

Mitselos, Anna ; Peeters, Theo L. ; Depoortere, Inge
Peptides. 29 (2008) 7 - p. 1167-1175 , 2008

Link: https://doi.org/10.1016/..

8

Differences in motilin receptor desensitization after stimu..:

Mitselos, Anna ; Berghe, Pieter Vanden ; Peeters, Theo L..
Biochemical Pharmacology. 75 (2008) 5 - p. 1115-1128 , 2008

Link: https://doi.org/10.1016/..

9

Delineation of the motilin domain involved in desensitizati..:

Mitselos, Anna ; Depoortere, Inge ; Peeters, Theo L.
Biochemical Pharmacology. 73 (2007) 1 - p. 115-124 , 2007

Link: https://doi.org/10.1016/..

10

Subcutaneous amivantamab (ami) in patients (pts) with advan..:

Minchom, Anna ; Krebs, Matthew ; Cho, Byoung...
Minchom , A , Krebs , M , Cho , B , Lee , S-H , Leighl , N , O'Neil , B , Sabari , J , Kudgus-Lokken , R , Alhadab , A , Haddish-Berhane , N , Zemlickis , D , Mitselos , A , Berkay , E , Bauml , J , Knoblauch , R , Hellemans , P & Johnson , M 2023 , ' Subcutaneous amivantamab (ami) in patients (pts) with advanced solid malignancies: The PALOMA study—Updated safety and identification of the recommended phase 2 dose. ' , Journal of Clinical Oncology , vol. 41 , no. 16_suppl , pp. 9126-9126 . https://doi.org/10.1200/JCO.2023.41.16_suppl.9126. , 2023

Link: https://research.manches..

11

Ibrutinib does not have clinically relevant interactions wi..:

de Jong, Jan ; Mitselos, Anna ; Jurczak, Wojciech...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506988/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Ibrutinib does not have clinically relevant interactions wi..:

Jong, J. (Jan) de ; Mitselos, A. (Anna) ; Jurczak, W. (Wojciech)...
https://hdl.handle.net/10171/66333. , 2020

Link: https://hdl.handle.net/1..

13

Pharmacokinetic Interactions between the Hepatitis C Virus ..:

Feng, Hwa-Ping ; Caro, Luzelena ; Fandozzi, Christine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437487/. , 2019

Link: http://www.ncbi.nlm.nih...

14

An open-label, multicenter, phase Ib study investigating th..:

Belderbos, B.P.S.I. (Bodine) ; Wit, R. (Ronald) de ; Chien, C. (Caly)...
http://repub.eur.nl/pub/114241. , 2018

Link: http://repub.eur.nl/pub/..

15

Discovery and Clinical Evaluation of MK‐8150, A Novel Nitri..:

Clayton D. Knox ; Pieter‐Jan deKam ; Karim Azer...
https://doi.org/10.1161/JAHA.116.003493. , 2016

Link: https://doi.org/10.1161/..